14 Jan

Notification of cessation of securities - MEB

Notification of cessation of +securities Notification of cessation of +securities 1 / 4 Announcement Summary Entity name MEDIBIO LIMITED Announcement Type New announcement Date of this announcement Friday January 14, 2022 Details of +securities that have ceased ASX +security code Security description Number of +securities that have ceased The +securities have ceased due to Date of cessation MEBAN OPTION EXPIRING 06-OCT-2023 EX $0.012 10,489,500 Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied 31/12/2021 Refer to next page for full details of the announcement Notification of cessation of +securities Notification of cessation of +securities 2 / 4 Part 1 - Announcement Details 1.1 Name of +Entity MEDIBIO LIMITED We (the entity named above) provide the following information about our issued capital. 1.2 Registered Number Type ABN Registration Number 58008130336 1.3 ASX issuer code MEB 1.4 The announcement is 1.5 Date of this announcement 14/1/2022 New announcement Notification of cessation of +securities Notification of cessation of +securities 3 / 4 Part 2 - Details of +equity securities or +debt securities that have ceased ASX +Security Code and Description MEBAN : OPTION EXPIRING 06-OCT-2023 EX $0.012 Unquoted +equity securities that have ceased Number of securities that have ceased 10,489,500 Reason for cessation Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied Date of cessation 31/12/2021 Is the entity paying any consideration for the cessation? Any other information the entity wishes to notify to ASX about the cessation? These options had vesting conditions of which certain conditions were not met and thus have lapsed. No Notification of cessation of +securities Notification of cessation of +securities 4 / 4 Part 3 - Issued capital following changes Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise: 3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX) ASX +security code and description Total number of +securities on issue MEB : ORDINARY FULLY PAID 2,061,051,123 MEBOC : OPTION EXPIRING 28-FEB-2024 205,111,009 MEBN : ORDINARY FULLY PAID DEFERRED 687,017,041 MEBO : OPTION EXPIRING 28-FEB-2024 DEFERRED 343,508,521 3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX) ASX +security code and description Total number of +securities on issue MEBAN : OPTION EXPIRING 06-OCT-2023 EX $0.012 10,210,500 MEBAD : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES 50,137,113 MEBAO : OPTION EXPIRING 08-DEC-2025 EX $0.011 11,250,000 MEBAE : OPTION EXPIRING 02-JUN-2022 EX 3C 27,500,000 Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form.

More from Medibio Limited


Join Listcorp to create a personalised news feed, follow your favourite companies, save useful news, and more.

By joining Listcorp you agree to our Terms & Conditions and Privacy Policy

Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2022 Listcorp. ABN 60 166 140 307

Never miss news from Medibio Limited (ASX:MEB) when you join Listcorp.